Search Results (2770)

  
Documents on biotech life sciences
 

View Page: Prev  1  2  3  4  5  6  7  8  9  10  Next  >>
Show: results per page
Sort by:
Sponsored Results

HTMLRevlon Removes Toxic Chemicals from Products
Stephen J. Burg; Burg Simpson Eldredge Hersh & Jardine, P.C.;
Legal Alert/Article
March 12, 2015, previously published on December 22, 2014
Consumers are becoming increasingly aware of ingredients found in everyday products that have harmful effects. While there are advocacy groups and organizations working to spread the word and insist these companies remove these ingredients , it is not always easy to effect change. However, the...

 

HTMLValeant Recalls Children’s Contaminated Respiratory Infection Treatment
Stephen J. Burg; Burg Simpson Eldredge Hersh & Jardine, P.C.;
Legal Alert/Article
March 12, 2015, previously published on January 5, 2015
Valeant Pharmaceuticals North America LLC voluntarily recalled one lot of its ribavirin powder for solutions, Virazole, according to a notification from the U.S. Food and Drug Administration.

 

HTMLDangers Affiliated with Cold Medicine
Stephen J. Burg; Burg Simpson Eldredge Hersh & Jardine, P.C.;
Legal Alert/Article
March 12, 2015, previously published on December 31, 2014
As winter settles in, so does the cold and flu season. It is time for many people to get their annual flu shots or go to the pharmacy and pick up a new bottle of cold medicine. However, reading the label is extremely important and is not done carefully enough, especially when it comes to children....

 

HTMLChildren’s Hoodies Recalled This December
Stephen J. Burg; Burg Simpson Eldredge Hersh & Jardine, P.C.;
Legal Alert/Article
March 12, 2015, previously published on December 31, 2014
Parents may need to return some of their children's Christmas presents since two separate recalls announced certain hoodies pose strangulation risks.

 

HTMLFDA Issues Second Warning About Powdered Caffeine
Stephen J. Burg; Burg Simpson Eldredge Hersh & Jardine, P.C.;
Legal Alert/Article
March 12, 2015, previously published on January 3, 2015
The U.S. Food and Drug Administration issued a second warning over the use of powdered caffeine. The move comes after two reported deaths in 2014 were linked directly with the product.

 

HTML2 Weight Loss Supplements Recalled For Containing Potentially Dangerous Drugs
Stephen J. Burg; Burg Simpson Eldredge Hersh & Jardine, P.C.;
Legal Alert/Article
March 12, 2015, previously published on December 24, 2014
Bethel Nutritional Consulting, Inc. recalled two of its products at the consumer level after the U.S. Food and Drug Administration found they contained undeclared medications. Bethel's SLIM-K and B-Lipo products both have ingredients that are unapproved drugs under federal law and could be...

 

HTMLFDA Believes Herbalife Video is Misleading
Stephen J. Burg; Burg Simpson Eldredge Hersh & Jardine, P.C.;
Legal Alert/Article
March 12, 2015, previously published on December 31, 2014
The Deputy Commissioner for Foods and Veterinary Medicine Michael Taylor of the U.S. Food and Drug Administration admonished Herbalife Ltd. for misleading consumers in a recent YouTube video and asked the company to take the video down.

 

HTMLNinth Circuit Affirms Finding That Hospital’s Acquisition of Medical Group Was Anticompetitive
Robert B. Craig; Taft Stettinius & Hollister LLP;
Legal Alert/Article
March 2, 2015, previously published on February 12, 2015
The Federal Trade Commission maintained its winning streak in health care merger cases after the 9th Circuit affirmed an Idaho district court’s ruling that the acquisition of Idaho’s largest physician group by one of the state’s largest health care systems violated Section 7 of...

 

HTMLBill Introduced in Congress Calls for Private Enforcement of All Food Regulations and Would Weaken Preemption Defenses
Jonathan Berman; Jones Day;
Legal Alert/Article
February 26, 2015, previously published on January 2015
Recent years have seen a surge in private class actions alleging that food labels are misleading or misbranded. The viability of many of these cases, however, has been limited by two important provisions of the Food, Drug, and Cosmetic Act ("FDCA"). Section 310 provides that only the...

 

HTMLSummary of Antares Pharma, Inc. v. Medac Pharma. Inc., 2014-1648
Sughrue Mion PLLC;
Legal Alert/Article
February 17, 2015, previously published on November 17, 2014
Within two years of the USPTO issuing a patent the Applicant may request the Office reissue the patent with enlarged claim scope, provided it is “for the invention disclosed in the original patent.” Antares sought and obtained a reissue of its U.S. Patent 7,776,015 (“the...

 


View Page: Prev  1  2  3  4  5  6  7  8  9  10  Next  >>